OBJECTIVE: To directly compare cancer incidence among Hispanic children and non-Hispanic white children in California and Florida, two states in the United States of America that include nearly one in three Hispanic children in the country. METHODS: Cross-sectional data for 1988 through 1998 pertaining to all incident pediatric cancer cases (age < 15 years) with race/ethnicity coded as either Hispanic or non-Hispanic white came from the Florida Cancer Data System database and the California Cancer Registry database. The results were expressed as age-standardized incidence rates, standardized to the world standard million population. Hispanic rates and non-Hispanic white rates were compared using standardized incidence ratios (SIRs) with 95% confidence intervals (95% CIs.). RESULTS: The SIR for all cancers for Hispanic children compared to non-Hispanic white children was 1.02 (95% CI: 0.99, 1.05). For selected tumor types, SIRs indicated higher incidences among Hispanic children for leukemia (SIR = 1.26; 95% CI: 1.19, 1.34), Hodgkin's lymphoma (SIR = 1.29; 95% CI: 1.08, 1.54), and germ cell tumors (SIR = 1.62; 95% CI: 1.34, 1.96). There were lower incidences for the Hispanic children for central nervous system tumors (SIR = 0.72; 95% CI: 0.66, 0.78) and for sympathetic nervous system tumors (SIR = 0.76; 95% CI: 0.66, 0.87). In terms of interstate differences, the incidence of lymphoma, central nervous system tumors, sympathetic nervous system tumors, and malignant bone tumors was highest among Hispanic youth in Florida; the incidence of hepatic tumors was highest among Hispanic youth in California. CONCLUSIONS: While the overall cancer incidence rate among Hispanic children was similar to that for non-Hispanic white children, significant differences for specific tumor types were identified. Since Hispanic ethnicity may be a confounder for other cancer risk factors (e.g., familial, socioeconomic, or environmental), it is recommended that future research into Hispanic pediatric cancer risk investigate these risk factors.
OBJECTIVE: To directly compare cancer incidence among Hispanic children and non-Hispanic white children in California and Florida, two states in the United States of America that include nearly one in three Hispanic children in the country. METHODS: Cross-sectional data for 1988 through 1998 pertaining to all incident pediatric cancer cases (age < 15 years) with race/ethnicity coded as either Hispanic or non-Hispanic white came from the Florida Cancer Data System database and the California Cancer Registry database. The results were expressed as age-standardized incidence rates, standardized to the world standard million population. Hispanic rates and non-Hispanic white rates were compared using standardized incidence ratios (SIRs) with 95% confidence intervals (95% CIs.). RESULTS: The SIR for all cancers for Hispanic children compared to non-Hispanic white children was 1.02 (95% CI: 0.99, 1.05). For selected tumor types, SIRs indicated higher incidences among Hispanic children for leukemia (SIR = 1.26; 95% CI: 1.19, 1.34), Hodgkin's lymphoma (SIR = 1.29; 95% CI: 1.08, 1.54), and germ cell tumors (SIR = 1.62; 95% CI: 1.34, 1.96). There were lower incidences for the Hispanic children for central nervous system tumors (SIR = 0.72; 95% CI: 0.66, 0.78) and for sympathetic nervous system tumors (SIR = 0.76; 95% CI: 0.66, 0.87). In terms of interstate differences, the incidence of lymphoma, central nervous system tumors, sympathetic nervous system tumors, and malignant bone tumors was highest among Hispanic youth in Florida; the incidence of hepatic tumors was highest among Hispanic youth in California. CONCLUSIONS: While the overall cancer incidence rate among Hispanic children was similar to that for non-Hispanic white children, significant differences for specific tumor types were identified. Since Hispanic ethnicity may be a confounder for other cancer risk factors (e.g., familial, socioeconomic, or environmental), it is recommended that future research into Hispanic pediatric cancer risk investigate these risk factors.
Authors: Olivia Carter-Pokras; Ruth E Zambrana; Carolyn F Poppell; Laura A Logie; Rafael Guerrero-Preston Journal: J Pediatr Health Care Date: 2007 Sep-Oct Impact factor: 1.812
Authors: Rekha Raghunathan; Swetha Mahesula; Kranthi Kancharla; Preethi Janardhanan; Yeshwant L A Jadhav; Robert Nadeau; German P Villa; Robert L Cook; Colleen M Witt; Jonathan A L Gelfond; Thomas G Forsthuber; William E Haskins Journal: Part Part Syst Charact Date: 2013-04 Impact factor: 3.310
Authors: María Luisa Pérez-Saldivar; Arturo Fajardo-Gutiérrez; Roberto Bernáldez-Ríos; Armando Martínez-Avalos; Aurora Medina-Sanson; Laura Espinosa-Hernández; José de Diego Flores-Chapa; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Francisco Javier Alvarez-Rodríguez; Victoria Bolea-Murga; Janet Flores-Lujano; María Del Carmen Rodríguez-Zepeda; Roberto Rivera-Luna; Elisa María Dorantes-Acosta; Elva Jiménez-Hernández; Martha Alvarado-Ibarra; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; David Aldebarán Duarte-Rodríguez; Rogelio Paredes-Aguilera; María de Los Ángeles Del Campo-Martínez; Rocío Cárdenas-Cardos; Paola Hillary Alamilla-Galicia; Vilma Carolina Bekker-Méndez; Manuel Carlos Ortega-Alvarez; Juan Manuel Mejia-Arangure Journal: BMC Cancer Date: 2011-08-17 Impact factor: 4.430
Authors: Lucero Valenzuela-Vazquez; Juan Carlos Núñez-Enríquez; Jacqueline Sánchez-Herrera; Elva Jiménez-Hernández; Jorge Alfonso Martín-Trejo; Laura Eugenia Espinoza-Hernández; Aurora Medina-Sanson; Luz Victoria Flores-Villegas; José Gabriel Peñaloza-González; José Refugio Torres-Nava; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Jessica Denisse Santillán-Juárez; Janet Flores-Lujano; María Luisa Pérez-Saldívar; Luis Ramiro García-López; Alejandro Castañeda-Echevarría; Francisco Rodríguez-Leyva; Haydeé Rosas-Vargas; Minerva Mata-Rocha; David Aldebarán Duarte-Rodríguez; Omar Alejandro Sepúlveda-Robles; Ismael Mancilla-Herrera; Juan Manuel Mejía-Aranguré; Mario Ernesto Cruz-Munoz Journal: PLoS One Date: 2020-01-17 Impact factor: 3.240